By Buck Daniel May 22, 2014 – Two defense verdicts in favor of Takeda have been reached in the past week. On May 15, an Illinois state court jury returned a defense verdict in an Actos bladder cancer death case after four weeks of testimony. Additionally today, a jury in […]
bladder cancer
6 posts
By Buck Daniel April 30, 2014 – Since our last update, there has been a great deal of activity in the Actos litigation. As of the end of March 2014, there were over 5,000 Actos cases filed in the MDL and Illinois State Court and another 1,000 still expected in […]
By Buck Daniel August 14, 2013 – Since our last update, several big developments have occurred in the nationwide Actos litigation. The first Actos lawsuit was tried outside of the MDL in Los Angeles, California, where the plaintiff, like all of our own clients, alleged that Takeda failed to warn […]
Posted by Buck Daniel November 7, 2012 – A consolidated complaint was filed by 12 plaintiffs, who claim to have been diagnosed with bladder cancer as a result of using Actos, on August 14, 2012. Specifically, the court documents allege that the defendants, Takeda Pharmaceuticals, should have known about the […]
June 1, 2012 – American Association for Justice Trial Magazine June 2012 Drugs & Devices: How Big Pharma Puts Patients at Risk “Bad Actos” by Howard L. Nations and John M. Restaino “The safety of Actos, an oral diabetes drug that increases the body’s sensitivity to insulin, has been increasingly […]
By Buck Daniels May 31, 2012 – In a linked study … Azoulay and colleagues found that more than two years daily exposure to pioglitazone doubled the risk of bladder cancer. Read the full PDF article on further evidence of bladder cancer here.